Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-217751
Filing Date
2017-06-29
Accepted
2017-06-29 11:25:03
Documents
4
Period of Report
2017-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d406477d6k.htm 6-K 8912
2 EX-99.1 d406477dex991.htm EX-99.1 447141
3 EX-99.2 d406477dex992.htm EX-99.2 28129
4 GRAPHIC g406477g68n46.jpg GRAPHIC 8972
  Complete submission text file 0001193125-17-217751.txt   497629
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 17937264
SIC: 2834 Pharmaceutical Preparations